Want to see CBIO full AI Analyst Report?
Crescent Biopharma (CBIO) Ownership Overview
11.26% Insiders
5.25% Mutual Funds
48.04% Other Institutional Investors
8.45% ETFs
27.00% Public Companies and
Individual Investors
The ownership structure of Crescent Biopharma (CBIO) stock is a mix of institutional, retail, and individual investors. Approximately 61.74% of the company’s stock is owned by Institutional Investors, 11.26% is owned by Insiders, and 27.00% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 20, 2026 | xxxxxxxxxxxxx | $12375025 | |
Dec 08, 2025 | xxxxxxxxxxxxx | $18237600 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $1127646 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $1700784 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,601,316 | Insider | 9.70% | 46,168,871 | |
| 2,747,866 | Institution | 7.40% | 35,227,642 | |
| 1,527,160 | Institution | 4.11% | 19,578,191 | |
| 1,086,017 | Institution | 2.92% | 13,922,738 | |
| 780,782 | Institution | 2.10% | 10,009,625 | |
| 466,381 | Institution | 1.26% | 5,979,004 | |
| 440,258 | Institution | 1.19% | 5,644,108 | |
| 302,457 | Institution | 0.81% | 3,877,499 | |
| 281,212 | Insider | 0.76% | 3,605,138 | |
| 251,090 | Institution | 0.68% | 3,218,974 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 780,782 | Institution | 2.10% | 10,009,625 | |
| 466,381 | Institution | 1.26% | 5,979,004 | |
| 251,090 | Institution | 0.68% | 3,218,974 | |
| 221,065 | Institution | 0.60% | 2,834,053 | |
| 113,421 | Institution | 0.31% | 1,454,057 | |
| 74,714 | Institution | 0.20% | 957,833 | |
| 12,607 | Institution | 0.03% | 161,622 | |
| 8,300 | Institution | 0.02% | 106,406 | |
| 8,006 | Institution | 0.02% | 102,637 | |
| 7,409 | Institution | 0.02% | 94,983 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 906,646 | Institution | 2.44% | 13,227,965 | |
| 715,070 | Institution | 1.93% | 9,167,197 | |
| 354,376 | Institution | 0.95% | 4,656,501 | |
| 332,978 | Institution | 0.90% | 4,858,149 | |
| 270,500 | Institution | 0.73% | 3,467,810 | |
| 168,996 | Institution | 0.45% | 2,465,652 | |
| 88,751 | Institution | 0.24% | 1,137,788 | |
| 62,581 | Institution | 0.17% | 913,057 | |
| 42,941 | Institution | 0.12% | 564,245 | |
| 31,678 | Institution | 0.09% | 462,182 |
FAQ
Who Owns Crescent Biopharma (CBIO)?
According to the latest TipRanks data, approximately 48.04% of the company's stock is held by institutional investors, 11.26% is held by insiders, and 27.00% is held by retail investors.
What percentage of Crescent Biopharma (CBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 48.04% of Crescent Biopharma (CBIO) stock is held by institutional investors.
What percentage of Crescent Biopharma (CBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.00% of Crescent Biopharma (CBIO) stock is held by retail investors.
Who owns the most shares of Crescent Biopharma (CBIO)?
Fairmount Funds Management LLC owns the most shares of Crescent Biopharma (CBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.